Provides a fully automated Medical, Legal, and Regulatory (MLR) material review engine that uses generative AI to evaluate promotional and non-promotional documents in real time. This platform ensures compliance with UK and Ireland regulations, reduces review cycle times, and maintains consistent quality by aligning with the latest industry standards. Tailored to individual compliance profiles, it optimizes operational efficiency for pharmaceutical companies and medical communications agencies.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical companies and medical communications agencies face challenges in ensuring that promotional and non-promotional materials comply with evolving Medical, Legal, and Regulatory (MLR) standards. Manual review processes are often slow, inconsistent, and costly, potentially leading to regulatory issues and delayed product launches.
Solution
Aithena provides an AI-powered engine that automates the review of promotional and non-promotional materials, ensuring compliance with the latest UK and Ireland regulations. The platform delivers real-time analysis, consistent review quality, and alignment with industry standards, reducing review cycle times and optimizing operational efficiency. Aithena's solution adapts to individual compliance profiles, providing tailored outputs that reflect each company's specific requirements. By automating the first line of MLR review, Aithena helps medical affairs and marketing teams focus on innovation and strategic initiatives.
Target Audience
The primary target audience includes pharmaceutical companies, medical communications agencies, medical affairs teams, and marketing teams involved in the creation and review of promotional and non-promotional materials.
Features
- Real-time material review using generative AI
- Consistent and objective review quality
- Alignment with the latest UK and Ireland compliance standards (with EU and international regulations planned)
- Adaptable to specific company compliance profiles
- Secure and private platform ensuring data accessibility is limited to the company